$CBIS "This is another ground-breaking product release. We expect our suppository regimens to help address a significant demand for cannabinoid-based medicines targeting several patient-specific indications. Through this limited release of unisex regimens to self-medicating patients, we expect to track the use of these products through the dispensary, and observe the effectiveness of this particular formulation and delivery system. This process, as part of an overall observation and testing protocol, will enable CBIS to develop products that can help the largest number of patients possible," stated Dr. Allen Herman, CBIS' Chief Medical Officer.
http://www.marketwired.com/press-release/cann...215769.htm
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!